Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > I share Redbaron's thoughts

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon Jan 14, 2022 2:15pm

163 Views

Post# 34318128

RE:RE:I share Redbaron's thoughts

Redbaron2211 wrote: Steadfast agree. At least its better then the -15% potential return he gave with last year's target. Doe Loe is corrupt or clueless and needs to go. Hopefully with a TSX listing we can attract some real analysts.

Red,

I agree with you totally . They need another analyst besides Loe . Graduating to Tsx won't make a difference imo. IR/PR is incompetent . Time to to fire Matthews .

Timing of Shapiro's media blitz is suspicious . Timing of 1 million shares dumped at market open is suspicious .

Long term shareholders are getting frustrated and losing patience .

At this rate , the biggest fear is that any good news will be sold into . And at that rate , company will never get on Nasdaq.

Ms Sally

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading